Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Relapsed/Refractory Waldenström's Macroglobulinemia
NCT00398710Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Oct 2006
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in Waldenström's macroglobulinemia (WM), sponsored by COSCIENS Biopharma Inc.. Started Oct 2006; status: completed.
02
Drugs
perifosine
03
Conditions
Waldenström's macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00398710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398710.